48 hedge funds and large institutions have $1.79M invested in BioVie in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

13% less call options, than puts

Call options by funds: $14K | Put options by funds: $16K

50% less capital invested

Capital invested by funds: $3.55M → $1.79M (-$1.76M)

59% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 17

Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14K
Puts
$16K
Net Calls
Net Calls Change

Top Buyers

1 +$70.6K
2 +$24.7K
3 +$17.6K
4
SM
Sabby Management
Florida
+$17.6K
5
YIH
Y-Intercept (HK)
Hong Kong
+$14.9K

Top Sellers

1 -$413K
2 -$317K
3 -$184K
4
BlackRock
BlackRock
New York
-$123K
5
State Street
State Street
Massachusetts
-$58.5K
Name Holding Trade Value Shares
Change
Change in
Stake
51
52
53
54
55
56
57
58
59
60